• Explore /
  • Poster
  • / Survival after isolated hepatic perfusion as a treatment for uveal melanoma liver metastases: Results from a randomized controlled trial (the SCANDIUM trial).

Survival after isolated hepatic perfusion as a treatment for uveal melanoma liver metastases: Results from a randomized controlled trial (the SCANDIUM trial).

Abstract Poster

Authors

Roger Olofsson Bagge

Roger Olofsson Bagge

Gothenburg University, Gothenburg, Sweden

Roger Olofsson Bagge , Axel Nelson , Amir Shafazand , Charlotta All-Eriksson , Christian Cahlin , Nils Elander , Hildur Helgadottir , Jens Folke Kiilgaard , Sara Kinhult , Ingrid Ljuslinder , Magnus Rizell , Malin Sternby Eilard , Gustav J. Ullenhag , Jonas A Nilsson , Lars Ny , Per Lindner

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Melanoma/Skin Cancers

Track

Melanoma/Skin Cancers

Sub Track

Advanced/Metastatic Disease

Clinical Trial Registration Number

NCT01785316

Citation

J Clin Oncol 41, 2023 (suppl 17; abstr LBA9512)

DOI

10.1200/JCO.2023.41.17_suppl.LBA9512

Abstract #

LBA9512

Poster Bd #

275

Abstract Disclosures

Similar Posters

First Author: Roger Olofsson Bagge

First Author: Roger Olofsson Bagge

First Author: Thaïs M.L. Tong

First Author: Rino S Seedor